| Human serum albumin nanoparticulate system with encapsulation of gefitinib for enhanced anti-tumor effects in non-small cell lung cancer | |
| Qian, Kang; Jiang, Xinguo; Cheng, Yunlong; Sheng, Dongyu; Wan, Xu; Guo, Qian; Zhang, Qizhi; Pang, Xiaoying; Yang, Peng; Wang, Liuchang | |
| 刊名 | JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
 |
| 2019 | |
| 卷号 | 52 |
| 关键词 | Gefitinib Human serum albumin nanoparticles Nab (TM) technology Oleic acid Non-small cell lung cancer |
| ISSN号 | 1773-2247 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3594759 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Qian, Kang,Jiang, Xinguo,Cheng, Yunlong,et al. Human serum albumin nanoparticulate system with encapsulation of gefitinib for enhanced anti-tumor effects in non-small cell lung cancer[J]. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY,2019,52. |
| APA | Qian, Kang.,Jiang, Xinguo.,Cheng, Yunlong.,Sheng, Dongyu.,Wan, Xu.,...&Cao, Jingxu.(2019).Human serum albumin nanoparticulate system with encapsulation of gefitinib for enhanced anti-tumor effects in non-small cell lung cancer.JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY,52. |
| MLA | Qian, Kang,et al."Human serum albumin nanoparticulate system with encapsulation of gefitinib for enhanced anti-tumor effects in non-small cell lung cancer".JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY 52(2019). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论